Conditional apoptosis induced by oncogenic ras in thyroid cells

Molecular Endocrinology

Volumn 14, Issue 11, 2000, Pages 1725-1738

  Shirokawa, J M ^a   Elisei, R ^a   Knauf, J A ^a   Hara, T ^a   Wang, J ^a   Saavedra, H I ^a   Fagin, J A ^a  

^a Vontz Center for Molecular Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; THYROTROPIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; HORMONE RESPONSE; IMMUNOBLOTTING; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID CELL;

EID: 0033646122     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.11.0559     Document Type: Article

References (42)

1. The ras gene family and human carcinogenesis
2. Interactions between Ras proteins and their effectors
3. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
4. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis
5. Ras signalling and apoptosis
6. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability
7. Suppression of c-Myc-induced apoptosis by Ras signalling through Pl(3)K and PKB
8. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
9. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs
10. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153
11. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
12. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
13. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells
14. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
15. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways
16. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
17. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
18. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
19. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)
20. Multiple mechanisms of interference between transformation and differentiation in thyroid cells
21. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1
22. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway
23. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: Suppression by mutant c-H-ras oncogene expression
24. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells
25. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras
26. Overexpression of mos oncogene product in Swiss 3T3 cells induces apoptosis preferentially during S-phase
27. Complexes of p21RAS with JUN N-terminal kinase and JUN proteins
28. An essential role for Rac in Ras transformation
29. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1)
30. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation
31. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways
32. The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway
33. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
34. Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase
35. Differential effects of protein kinase A on Ras effector pathways
36. Stimulation of cell proliferation and inhibition of differentiation expression by tumor-promoting phorbol esters in dog thyroid cells in primary culture
37. Mechanism of inhibition of Raf-1 by protein kinase A
38. Effect of serum growth factors and phorbol ester on growth and survival of human thyroid epithelial cells expressing mutant ras
39. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: Identification of additional mutations activating both the cyclic adenosine 3',5'-rnonophosphate and inositol phosphate-Ca2+ cascades
40. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
41. Transcriptional activation by tetracyclines in mammalian cells
42. Involvement of protein kinase Cε (PKCε)in thyroid cell death. A truncated chimeric PKCε cloned from a thyroid cancer cell line protects thyroid cells from apoptosis